Good news doesn't travel to every corner. The overall market rose yet again, but shareholders of three health-care stocks are certainly not singing a happy tune after the past week.

One of the big losers could just be experiencing the effects of profit-taking after a huge stock run-up. Another felt the sting of an analyst report citing concerns about a clinical study in progress. Yet another absorbed the impact of announcing a big secondary offering that dilutes existing shareholders' stock value.

Which stocks were crushed badly by the market this week? Find out by watching the following slideshow.